Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | WDR5 | P61964 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | ACP1 | P24666 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20854927 | 0.83 | NPC1 (0.46) | NPC1RAB9AKDM4EHTTKMT2A | |
| SCHEMBL20854973 | 0.77 | HIF1A (0.45) | WDR5NPC1RAB9APDCD1CD274 | |
| SCHEMBL13677263 | 0.75 | HRH4 (0.47) | NPC1RAB9AHTTLMNAPDCD1 | |
| SCHEMBL16003898 | 0.73 | CKS1B (0.40) | PDCD1CD274ADORA1POLBADORA3 | |
| SCHEMBL11257628 | 0.72 | NPC1 (0.57) | ALDH1A1WDR5NPC1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL16341064 | 0.72 | CKS1B (0.40) | PDCD1CD274ADORA1POLBADORA3 | |
| SCHEMBL13676974 | 0.71 | OGA (0.45) | NPC1RAB9ALMNAPDCD1CD274 | |
| SCHEMBL20141429 | 0.71 | DPP4 (0.54) | RAB9ANR1H2NR1H3KMT2AMEN1 | |
| SCHEMBL16003887 | 0.70 | PDE10A (0.45) | ALDH1A1KDM4ELMNANR1H2NR1H3 | |
| SCHEMBL14520436 | 0.69 | NR1H3 (0.43) | NPC1RAB9APDCD1CD274NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975095-B2 | — | — | 2021-04-13 | — | — | US | disclosed |
| US-20190100530-A1 | BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2019-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190100530-A1 | BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF | HSD17B7, CYP11B1, CYP11B2 | ALDH1A1 184/4885WDR5 3655/4885NPC1 192/4885 |
| US-10975095-B2 | — | CYP1B1, UGT1A1, CYP4B1 | ALDH1A1 286/4885WDR5 2168/4885NPC1 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.